ES8103171A1 - Un procedimiento de preparacion de monacolina k. - Google Patents

Un procedimiento de preparacion de monacolina k.

Info

Publication number
ES8103171A1
ES8103171A1 ES488796A ES488796A ES8103171A1 ES 8103171 A1 ES8103171 A1 ES 8103171A1 ES 488796 A ES488796 A ES 488796A ES 488796 A ES488796 A ES 488796A ES 8103171 A1 ES8103171 A1 ES 8103171A1
Authority
ES
Spain
Prior art keywords
antihypercholesteraemic
monacolin
agent
preparation
monascus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488796A
Other languages
English (en)
Spanish (es)
Other versions
ES488796A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES8103171A1 publication Critical patent/ES8103171A1/es
Publication of ES488796A0 publication Critical patent/ES488796A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES488796A 1979-02-20 1980-02-20 Un procedimiento de preparacion de monacolina k. Granted ES488796A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (2)

Publication Number Publication Date
ES8103171A1 true ES8103171A1 (es) 1981-02-16
ES488796A0 ES488796A0 (es) 1981-02-16

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488796A Granted ES488796A0 (es) 1979-02-20 1980-02-20 Un procedimiento de preparacion de monacolina k.

Country Status (27)

Country Link
JP (1) JPS5925599B2 (da)
KR (1) KR830002801B1 (da)
AT (1) AT373915B (da)
AU (1) AU532626B2 (da)
BE (1) BE881825A (da)
CA (1) CA1129794A (da)
CH (1) CH645890A5 (da)
DD (1) DD154494A5 (da)
DE (2) DE3006216C2 (da)
DK (2) DK149095C (da)
ES (1) ES488796A0 (da)
FI (1) FI66427C (da)
FR (1) FR2449685B1 (da)
GB (1) GB2046737B (da)
HU (1) HU182069B (da)
IE (1) IE49743B1 (da)
IT (1) IT1175260B (da)
MX (1) MX6314E (da)
NL (1) NL191540C (da)
NO (1) NO153974C (da)
NZ (1) NZ192919A (da)
PH (1) PH15145A (da)
PL (1) PL124304B1 (da)
SE (1) SE453301B (da)
SG (1) SG6784G (da)
SU (2) SU1158048A3 (da)
ZA (1) ZA80962B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
WO1993017991A1 (en) * 1992-03-04 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
IL132822A0 (en) 1998-03-20 2001-03-19 Biogal Gyogyszergyar Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
SK12012002A3 (sk) 2000-02-24 2003-02-04 Biogal Gyogyszergyar Rt. Spôsob purifikácie fermentačného bujónu
CZ20023201A3 (cs) 2000-03-03 2003-09-17 Plus Chemicals S. A. Způsob čištění lovastatinu a simvastatinu na produkt se sníženou hladinou dimerních nečistot
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (da) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
DE60218822T2 (de) * 2001-02-09 2007-07-12 Unilever N.V. Nahrungsmittel enthaltend sojaprotein und statin
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (da) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
GR69216B (da) * 1979-06-15 1982-05-07 Merck & Co Inc

Also Published As

Publication number Publication date
SU969702A1 (ru) 1982-10-30
MX6314E (es) 1985-04-01
HU182069B (en) 1983-12-28
NL191540C (nl) 1995-09-04
ATA92980A (de) 1983-07-15
AU5567380A (en) 1980-08-28
SG6784G (en) 1985-02-08
FI800506A (fi) 1980-08-21
PH15145A (en) 1982-08-24
DK21889D0 (da) 1989-01-18
JPS5925599B2 (ja) 1984-06-19
NO153974B (no) 1986-03-17
BE881825A (fr) 1980-08-20
PL222120A1 (da) 1980-10-20
DK73080A (da) 1980-08-21
DD154494A5 (de) 1982-03-24
KR830002030A (ko) 1983-05-21
NO153974C (no) 1986-06-25
IT8067262A0 (it) 1980-02-20
FR2449685B1 (fr) 1985-06-28
AU532626B2 (en) 1983-10-06
CH645890A5 (de) 1984-10-31
IE800321L (en) 1980-08-20
DK149095B (da) 1986-01-20
SE453301B (sv) 1988-01-25
FI66427B (fi) 1984-06-29
GB2046737A (en) 1980-11-19
IE49743B1 (en) 1985-12-11
GB2046737B (en) 1983-01-12
SU1158048A3 (ru) 1985-05-23
NZ192919A (en) 1984-07-06
NL8001041A (nl) 1980-08-22
DE3006216A1 (de) 1980-09-04
JPS55111790A (en) 1980-08-28
DE3051175C2 (da) 1989-12-21
AT373915B (de) 1984-03-12
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
NL191540B (nl) 1995-05-01
IT1175260B (it) 1987-07-01
SE8001339L (sv) 1980-08-21
CA1129794A (en) 1982-08-17
DK21889A (da) 1989-01-18
PL124304B1 (en) 1983-01-31
DK149095C (da) 1986-06-16
ZA80962B (en) 1981-03-25
DE3006216C2 (de) 1985-10-31
NO800451L (no) 1980-08-21
ES488796A0 (es) 1981-02-16
KR830002801B1 (ko) 1983-12-16

Similar Documents

Publication Publication Date Title
ES8103171A1 (es) Un procedimiento de preparacion de monacolina k.
ES8106177A1 (es) Un procedimiento para la preparacion de nuevos antibioticos de milbecina.
AU565322B2 (en) Substances from actinomadura strains
JPS56113718A (en) Bifunctional terpenoid, its preparation, and ulcer preventive agent comprising it
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
JPS53121998A (en) Preparation of maytansiol, maytansine and maytansinol propionate
JPS53145984A (en) Preparation of vitamin b12 by fermentation
ES472318A1 (es) Un metodo para preparar el antibiotico c-14482 a.
ES8104400A1 (es) Un procedimiento para la produccion de un nuevo antibiotico designado com substancia bn-183 b.
ES480904A1 (es) Un procedimiento para la produccion del antibiotico mycopla-necin.
JPS5651992A (en) Preparation of physiologically active substance ml-236b
JPS57170189A (en) Dc-52 and its preparation
JPS57139080A (en) 14,15-epoxy derivative of antibiotic substance b-41 and its preparation
JPS56113721A (en) Preparation of bifunctional terpenoid
IE46064L (en) Antibiotic c-15003
JPS5341482A (en) Preparation of marine methanol-assimilable bacterial cells
JPS53127892A (en) Preparation of alpha-methyl-l-dopa
JPS5266691A (en) Preparation of carcinostatic agent
JPS5455778A (en) Microbial decomposition of styrene oligomer
JPS5654152B2 (da)
JPS57139079A (en) 8,9-epoxy derivative of antibiotic substance b-41 and its preparation
JPS5417182A (en) Preparation of choline-oxidase
JPS5391190A (en) Preparation of 5'-ribonucleoside
JPS5428893A (en) Preparation of sarcosine oxidase
GR900100078A (el) Ενώσεις αλτρομυκίνης.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010217